Holen Sie sich die Stockscreener-App
10.74
1.74%
-0.19
Handel nachbörslich:
10.76
0.02
+0.19%
Schlusskurs vom Vortag:
$10.93
Offen:
$11.24
24-Stunden-Volumen:
205.11K
Relative Volume:
0.95
Marktkapitalisierung:
$296.26M
Einnahmen:
$30.43M
Nettoeinkommen (Verlust:
$-18.15M
KGV:
-12.64
EPS:
-0.85
Netto-Cashflow:
$-9.08M
1W Leistung:
-5.87%
1M Leistung:
-20.21%
6M Leistung:
+73.23%
1J Leistung:
+108.14%
1-Tages-Spanne:
$10.70
$11.32
1-Wochen-Bereich:
$10.70
$12.82
52-Wochen-Spanne:
$5.105
$14.12
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Vergleichen Sie CLPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| CLPT | 10.74 | 296.26M | 30.43M | -18.15M | -9.08M | -0.85 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-03-18 | Eingeleitet | Lake Street | Buy |
| 2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
(CLPT) Investment Analysis - Stock Traders Daily
ClearPoint Neuro Inc (CLPT) Trading 6.12% Higher on Nov 14 - GuruFocus.com
ClearPoint (CLPT) Gains An FDA Approval, Driving Market Interest - Stocks Telegraph
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Deliv - PharmiWeb.com
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain - AccessWire
ClearPoint Neuro Makes History with First FDA-Approved Brain Gene Therapy Device | CLPT Stock News - StockTitan
ClearPoint Neuro fully repays $10M converted note - MSN
Q1 Earnings Estimate for CLPT Issued By B. Riley - MarketBeat
ClearPoint Neuro: Near-Term Volatility Is No Concern - Seeking Alpha
The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts - Yahoo Finance
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: ClearPoint Neuro reports robust Q3 growth, eyes FDA approvals - Investing.com
ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
ClearPoint Neuro, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Tops Revenue Estimates - MSN
ClearPoint Neuro Achieves Record Q3 Revenue Growth - TipRanks
Clearpoint Neuro earnings missed, revenue topped estimates By Investing.com - Investing.com UK
ClearPoint Neuro Reports Third Quarter 2024 Results - AccessWire
ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: Wha - GuruFocus.com
ClearPoint Neuro Inc (CLPT) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Those who invested in ClearPoint Neuro (NASDAQ:CLPT) five years ago are up 213% - Yahoo Finance
(CLPT) Trading Report - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in ClearPoint Neuro I - GuruFocus.com
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024 - AccessWire
ClearPoint Neuro: Investors Enamored With Its Growth Prospects (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (CLPT) Set to Announce Quarterly Earnings on Thursday - MarketBeat
ClearPoint Neuro, Inc. (NASDAQ:CLPT) Sees Significant Increase in Short Interest - MarketBeat
Taylor Frigon Capital Management LLC Has $4.20 Million Stock Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
CLPTClearPoint Neuro, Inc. Latest Stock News & Market Updates - StockTitan
ClearPoint Neuro (CLPT) Soars 6.9%: Is Further Upside Left in the Stock? - MSN
Investors bid ClearPoint Neuro (NASDAQ:CLPT) up US$51m despite increasing losses YoY, taking five-year CAGR to 27% - Simply Wall St
CLPT Stock Touches 52-Week High at $13.5 Amidst Strong Yearly Growth - Investing.com
ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024 - ForexTV.com
ClearPoint Neuro, Inc. (CLPT): A Bear Case Theory - Insider Monkey
Cubist Systematic Strategies LLC Takes $419,000 Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Cubist Systematic Strategies LLC Acquires Shares of 77,750 ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Marshall Wace LLP Buys 38,984 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
Squarepoint Ops LLC Takes $549,000 Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Renaissance Technologies LLC Acquires 144,088 Shares of ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Cubist Systematic Strategies LLC Takes Position in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - MarketBeat
Learn to Evaluate (CLPT) using the Charts - Stock Traders Daily
Point72 Asia Singapore Pte. Ltd. Makes New Investment in ClearPoint Neuro, Inc. (NASDAQ:CLPT) - Defense World
(CLPT) Investment Analysis and Advice - Stock Traders Daily
Believ acquires’ SMS Public EV Charging to accelerate charge point rollout - Fleet World
FDA Clears Neuroblade System For Minimally Invasive Neurosurgery - MPO-mag
The Good News and Bad News From ChargePoint's Q2 Results - sharewise
Investors Appear Satisfied With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Prospects As Shares Rocket 28% - Simply Wall St
It makes sense and dollars to buy ClearPoint Neuro Inc (CLPT) stock - SETE News
Is ClearPoint Neuro Inc (CLPT) a good investment opportunity? - US Post News
57,015 Shares in ClearPoint Neuro, Inc. (NASDAQ:CLPT) Purchased by Rinkey Investments - MarketBeat
Clearpoint Neuro shares target raised by Lake Street with Buy rating - Investing.com
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):